STVN:NYE-Stevanato Group SpA (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 21.74

Change

+0.74 (+3.52)%

Market Cap

USD 6.36B

Volume

0.34M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

+0.37 (+0.16%)

USD 66.03B
ALC Alcon AG

-0.65 (-0.75%)

USD 41.92B
RMD ResMed Inc

-0.70 (-0.30%)

USD 34.83B
BAX Baxter International Inc

-0.10 (-0.34%)

USD 16.24B
AVTR Avantor Inc

-0.07 (-0.33%)

USD 14.44B
ATR AptarGroup Inc

-0.70 (-0.44%)

USD 11.39B
TFX Teleflex Incorporated

-0.63 (-0.35%)

USD 8.27B
BLCO Bausch + Lomb Corp

-0.17 (-0.94%)

USD 7.27B
WRBY Warby Parker Inc

-0.61 (-2.44%)

USD 2.84B
INFU InfuSystems Holdings Inc

-0.02 (-0.25%)

USD 0.18B

ETFs Containing STVN

CIC:CA CI Canadian Banks Covered.. 17.36 % 0.84 %

+0.03 (+0.20%)

N/A
BANK:CA Evolve Canadian Banks and.. 12.46 % 0.39 %

+0.04 (+0.20%)

CAD 0.33B
BNC:CA Purpose Canadian Financia.. 11.49 % 0.68 %

-0.17 (0.20%)

N/A
CEW:CA iShares Equal Weight Banc.. 10.02 % 0.60 %

+0.05 (+0.20%)

CAD 0.24B
RBNK:CA RBC Canadian Bank Yield I.. 8.37 % 0.33 %

+0.05 (+0.20%)

CAD 0.28B
HEF:CA 7.74 % 0.83 %

N/A

N/A
HCB:CA 6.95 % 0.65 %

N/A

N/A
HCA:CA Hamilton Canadian Bank Me.. 6.57 % 0.00 %

-0.01 (0.20%)

CAD 0.07B
FIE:CA iShares Canadian Financia.. 5.80 % 0.97 %

+0.02 (+0.20%)

CAD 1.09B
BFIN-U:CA 5.72 % 0.00 %

N/A

N/A
NDIV:CA NBI Canadian Dividend Inc.. 4.59 % 0.00 %

N/A

CAD 0.02B
NSCE:CA NBI Sustainable Canadian .. 4.32 % 0.00 %

N/A

CAD 1.98B
INOC:CA Global X Inovestor Canadi.. 4.19 % 0.66 %

+0.06 (+0.20%)

CAD 0.04B
MCLC:CA Manulife Multifactor Cana.. 3.54 % 0.45 %

-0.10 (0.20%)

CAD 0.35B
XESG:CA iShares ESG Aware MSCI Ca.. 2.95 % 0.00 %

-0.09 (0.20%)

CAD 0.46B
FBE:CA 2.65 % 0.83 %

N/A

N/A
DXIF:CA Dynamic Active Internatio.. 0.00 % 0.00 %

+0.05 (+0.20%)

CAD 6.39M

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -20.34% 26% F 12% F
Dividend Return 0.21% 10% F 2% F
Total Return -20.12% 26% F 11% F
Trailing 12 Months  
Capital Gain -21.43% 26% F 12% F
Dividend Return 0.21% 10% F 2% F
Total Return -21.22% 26% F 11% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 12.37% 68% D+ 70% C-
Dividend Return 12.38% 68% D+ 65% D
Total Return 0.01% 10% F 1% F
Risk Return Profile  
Volatility (Standard Deviation) 42.51% 53% F 23% F
Risk Adjusted Return 29.12% 74% C 43% F
Market Capitalization 6.36B 43% F 80% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.